Navigation Links
Prime Therapeutics Announces URAC Accreditation
Date:10/13/2010

ST. PAUL, Minn., Oct. 13 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today it has been awarded full Pharmacy Benefit Management (PBM) accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. Prime received initial full Pharmacy Benefit Management URAC accreditation in 2007, and has also achieved URAC accreditation for its Medication Therapy Management program and for PrimeMail®, the organization's prescription home delivery service.

The URAC PBM accreditation program is designed to encourage PBM industry best practices, promote quality improvement and protect and empower consumers. The URAC standards development process is consensus driven, with hundreds of industry experts serving as volunteers to establish and revise appropriate industry benchmarks.

"At Prime, we strive for continual process improvement in the quality of products and services we provide to our clients and their members; achieving URAC reaccreditation clearly demonstrates that commitment," said Eric Elliott, President and Chief Executive Officer, Prime. "Accreditation also validates Prime's commitment to delivering inventive pharmacy solutions that keep member care and safety front and center."

Accreditation sets industry-wide clinical and operational standards and brings a recognizable seal of quality to accredited organizations. It is URAC's goal to develop accreditation standards and provide the assurance that, notwithstanding different business models, the content of what is provided to clients and their members meets acceptable standards.

"By applying for and receiving full Pharmacy Benefit Management accreditation, Prime Therapeutics has demonstrated a commitment to quality health care," said Alan P. Spielman, URAC president and CEO. "Quality health care is crucial to our nation's welfare and it is important to have organizations that are willing to measure themselves against national standards."

URAC, an independent, nonprofit organization, is a leader in promoting health care quality

through accreditation and certification programs. URAC's standards keep pace with the rapid

changes in the health care system, and provide a mark of distinction for health care organizations

to demonstrate their commitment to quality and accountability. Through its broad-based

governance structure and an inclusive standards development process, URAC ensures that all

stakeholders are represented in setting meaningful standards for the health care industry. For

more information, visit www.urac.org.

Prime Therapeutics LLC is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives*, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.

*As of January 1, 2011


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
2. Massachusetts Regional Extension Center Selects Greenways PrimeSuite
3. Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith
4. Siemens Primed to Help Customers Achieve Newly-Defined Criteria for Meaningful Use of an Electronic Health Record
5. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
6. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
7. Greenway Medical Technologies PrimeSuite Wins Three Best in KLAS Awards
8. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
9. Prime Therapeutics Receives 2010 TIPPS Certification for Adherence to High Transparency Standards
10. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
11. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research ... Health Market Analysis & Trends - Industry Forecast to 2025" ... ... at a CAGR of around 23.8% over the next decade to ... analyzes the market estimates and forecasts for all the given segments ...
(Date:2/24/2017)... Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow ... approximately $2.9 billion by 2025. This industry report analyzes ... as well as regional levels presented in the research scope. The study ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide ... with a specific LRRK2 mutation, according to a study released today at the ... evidence of a link between pesticides and incidence of sporadic PD through occupational ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release ... show in Cannes (France), XO Private has initiated a second print-run of its lavish ... almost a metre across when open, weighs in at more than six kilos, retails ...
Breaking Medicine News(10 mins):